Parallel Advisors, LLC

Position in ONC — BeOne Medicines Ltd.

CIK 1690010 SAN FRANCISCO, CA

Position in ONC

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$97,459

-$6,777 QoQ

Shares Held

342

-2.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#219

of 282 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. ONC ranks #32 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CORT	Corcept Therapeutics Inc	3,962,177	$344,511,290
2	VRTX	Vertex Pharmaceuticals Inc / Ma	5,389	$2,676,877
3	RCUS	Arcus Biosciences, Inc.	86,557	$2,668,552
4	REGN	Regeneron Pharmaceuticals, Inc.	1,063	$662,823
5	KRYS	Krystal Biotech, Inc.	1,699	$631,467
6	ARGX	Argenx SE	640	$593,772
7	INCY	Incyte Corp	4,961	$562,378
8	VKTX	Viking Therapeutics, Inc.	13,833	$539,625

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$97,459	342	-2.6%	Shares	Sole	2026-08-05
2026-03-31	$104,236	351	+24.0%	Shares	Sole	2026-05-07
2025-12-31	$85,978	283	+10.1%	Shares	Sole	2026-02-11
2025-09-30	$87,559	257	+4.9%	Shares	Sole	2025-11-13
2025-06-30	$59,307	245	+1.7%	Shares	Sole	2025-07-08
2025-03-31	$65,592	241	+15.3%	Shares	Sole	2025-04-08
2024-12-31	$38,604	209	-2.3%	Shares	Sole	2025-02-10
2021-12-31	$57,979	214	+3.4%	Shares	Sole	2022-01-20
2021-09-30	$75,141	207	+11.9%	Shares	Sole	2021-11-02
2021-06-30	$63,490	185	+22.5%	Shares	Sole	2021-08-06
2021-03-31	$52,560	151	+11.9%	Shares	Sole	2021-04-23
2020-12-31	$34,882	135	+35.0%	Shares	Sole	2021-02-02
2020-09-30	$28,644	100	+35.1%	Shares	Sole	2020-10-27
2020-06-30	$13,941	74	-60.2%	Shares	Sole	2020-07-16
2020-03-31	$22,898	186	—	Shares	Sole	2020-04-27
No filing history on record for this holder in this stock.